Close Menu

NEW YORK (GenomeWeb) – As part of its High-Risk/High-Reward Research Program, the National Institutes of Health has awarded a University of California, San Diego investigator a five-year, $3.8 million grant to develop a technology to map complete RNA interactomes in cells or tissues using high-throughput DNA sequencing.

According to UCSD's Sheng Zhong, the funding will be used to further refine the technology, as well as to investigate the mechanisms underlying cell fate decisions in early mammalian development.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.